'Limb fat' diaporamas de présentation

Antiretroviral Update Spring 2008

Antiretroviral Update Spring 2008. Lisa M. Chirch, M.D. Stony Brook University - CPHE NY/NJ AIDS Education and Training Center. Objectives. Review DHHS guidelines and most recent changes / additions Overview of recent significant clinical trial results

1.23k views • 99 slides

Manuel Battegay Div. Infectious Diseases & Hospital Epidemiology

Manuel Battegay Div. Infectious Diseases & Hospital Epidemiology. HIV complications and morbidity. Content. Introduction Selected specific adverse events ART and body shape changes ART, HIV and metabolism Cardiovascular risk general remarks ART and Lipids

751 views • 62 slides

David A Cooper National Centre in HIV Epidemiology and Clinical Research

Lipodystrophy and metabolic disorders in HIV disease. David A Cooper National Centre in HIV Epidemiology and Clinical Research The University of New South Wales Sydney, Australia. Lipoatrophy. Fat accumulation. Cytokines and tissue inflammation in lipoatrophy.

538 views • 42 slides

G Moyle 1 , C Sabin 2 , J Cartledge 3 , M Johnson 2 , E Wilkins 4 , D Churchill 5 ,

A Randomised, Open-Label Comparative Trial of Abacavir or Tenofovir DF as Replacement for a Thymidine Analogue in Persons with Lipoatrophy and Suppressed HIV RNA on HAART The RAVE Study. G Moyle 1 , C Sabin 2 , J Cartledge 3 , M Johnson 2 , E Wilkins 4 , D Churchill 5 ,

342 views • 23 slides

UK-CAB November 2005 Feedback from 7th Lipodystrophy Workshop 13-16 November, Dublin

443 views • 17 slides

ICAAC 2005

Changes in Lipids in Randomised, Open-Label Comparative Trial of Abacavir or Tenofovir DF as Replacement for a Thymidine Analogue in Persons with Lipoatrophy and Suppressed HIV RNA on HAART The RAVE Study. G Moyle 1 , C Sabin 2 , J Cartledge 3 , M Johnson 2 , E Wilkins 4 , D Churchill 5 ,

360 views • 16 slides

Switch studies in virologically suppressed patients

271 views • 8 slides